Form 4: Veracyte Executive Sells Shares
Insider Transaction (Form 4)
Phillip G. Febbo, Chief Scientific & Med Officer of Veracyte, Inc., sold 13,110 shares of common stock on September 2, 2026.
Summary
- Tax/exercise-price withholding: disposed of 3,639 Common Stock at $44.88 ($163,318) on September 2, 2026; holds 146,158 after (Direct).
- Open-market sale: disposed of 10,405 Common Stock at $42.89 ($446,305) on September 4, 2026; holds 135,753 after (Direct).
- Open-market sale: disposed of 2,705 Common Stock at $43.66 ($118,105) on September 4, 2026; holds 133,048 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $564,410 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Phillip G. Febbo — Officer (Chief Scientific & Med Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Tax/exercise-price withholding | Common Stock | 3,639 | $45 | $163.3K | 146,158 |
| 2026-09-04 | Open-market sale | Common Stock | 10,405 | $43 | $446.3K | 135,753 |
| 2026-09-04 | Open-market sale | Common Stock | 2,705 | $44 | $118.1K | 133,048 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Tax/exercise-price withholding (3,639 shares) |
| 2026-09-04 | Open-market sale (10,405 shares) |
| 2026-09-04 | Open-market sale (2,705 shares) |
Keywords
insider transaction, Form 4, VCYT, VERACYTE, INC., bearish, Phillip G. Febbo
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.